Method to study the effect of blend flowability on the homogeneity of acetaminophen

Drug Development and Industrial Pharmacy

Volumn 39, Issue 2, 2013, Pages 252-258

  Llusá, Marcos ^a,c   Pingali, Kalyana ^b   Muzzio, Fernando J ^c  

^a RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH   (Austria)

^b Western Michigan University   (United States)

^c The State University of New Jersey   (United States)

Author keywords

Acetaminophen; Blend homogeneity; Microcrystalline cellulose; Powder flow; Shear mixing

Indexed keywords

MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; PARACETAMOL;

ARTICLE; DRUG FORMULATION; PARTICLE SIZE; POWDER FLOW; SEGREGATION ANALYSIS;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; LUBRICATION; TECHNOLOGY, PHARMACEUTICAL;

EID: 84872451059     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.672424     Document Type: Article

References (23)

1. Llusá M, Kurt Sturm K, Sudah O, Stamato H, Goldfarb DJ, Ramachandruni H, Hammond S, Smith MR, Muzzio FJ. (2009). Effect of high shear blending protocols and blender parameters on the degree of API agglomeration in solid formulations. Ind Eng Chem Res, 48:93-101.
2. Rohrs BR, Amidon GE, Meury RH, Secreast PJ, King HM, Skoug CJ. (2006). Particle size limits to meet USP content uniformity criteria for tablets and capsules. J Pharm Sci, 95:1049-1059. (Pubitemid 43723164)
3. Zhang Y, Johnson KC. Effect of drug particle size on content uniformity of low-dose solid dosage forms. (1997). Int J Pharm, 154:179-183. (Pubitemid 27351322)
4. Morris DG, Truitt BF, Kong A, Leyva N, Luner PE. (2009). Influence of formulation composition and processing on the content uniformity of low-dose tablets manufactured at kilogram scale. Pharm Dev Technol, 14:451-460.
5. Lachiver ED, Abatzoglou N, Cartilier L, Simard JS. (2006). Agglomeration tendency in dry pharmaceutical granular systems. Eur J Pharm Biopharm, 64:193-199. (Pubitemid 44291987)
6. Ely D, Chamarthy S, Carvajal MT. (2006). An investigation into low dose blend uniformity and segregation determination using NIR spectroscopy. Colloid Surface Physicochem Eng Aspect, 288:71-76. (Pubitemid 44233239)
7. Bertrand F, Leclaire LA, Levecque G. (2005). DEM-based models for the mixing of granular materials. Chem Eng Sci, 60:2517-2531. (Pubitemid 40306802)
8. Campbell CS. Granular material flows-An overview. (2006). Powder Tech, 162:208-229.
9. Faqih A, Chaudhuri B, Alexander AWA, Hammond S, Muzzio FJ, Tomassone MS. (2006). Dilation effects of cohesive granular material in a rotating drum: experiments and Simulations. AlChE Journal, 52:4124-4132.
10. Faqih AM, Mehrotra A, Hammond SV, Muzzio FJ. (2007). Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int J Pharm, 336:338-345. (Pubitemid 46670664)
11. Bridgwater J. (1976). Fundamental powder mixing mechanisms. Powder Tech, 15:215-236.
12. Llusa M, Levin M, Snee RD, Muzzio FJ. (2009). Shear-induced APAP de-agglomeration. Drug Dev Ind Pharm, 35:1487-1495.
13. Almaya A, Aburub A. (2008). Effect of particle size on compaction of materials with different deformation mechanisms with and without lubricants. AAPS PharmSciTech, 9:414-418.
14. Doelker E, Massuelle D, Veuillez F, Humbert-Droz P. Morphological, packing, flow and tableting properties of new Avicel types. (1995). Drug Dev Ind Pharm, 21:643-661.
15. Reich G. (2005). Near-infrared spectroscopy and imaging: basic principles and pharmaceutical applications. Adv Drug Deliv Rev, 57:1109-1143. (Pubitemid 40797572)
16. Jivraj II, Martini LG, Thomson CM. (2000). An overview of the different excipients useful for the direct compression of tablets. Pharm Sci Technol Today, 3:58-63. (Pubitemid 30101632)
17. Cartilier LH, Moës AJ. (1986). Effect of Flowing Adjuvants on the Homogeneity and the Kinetics of Mixing of Low Dosage Cohesive Powder Mixtures. Drug Dev Ind Pharm, 12:1203-1218. (Pubitemid 16064255)
18. Sudah OS, Arratia PE, Coffin-Beach D, Muzzio FJ. (2002). Mixing of cohesive pharmaceutical formulations in tote (bin) blenders. Drug Dev Ind Pharm, 28:905-918.
19. Muzzio FJ, Goodridge CL, Alexander A, Arratia P, Yang H, Sudah O et al. (2003). Sampling and characterization of pharmaceutical powders and granular blends. Int J Pharm, 250:51-64. (Pubitemid 35447937)
20. Duong NH, Arratia P, Muzzio F, Lange A, Timmermans J, Reynolds S. (2003). A homogeneity study using NIR spectroscopy: tracking magnesium stearate in Bohle bin-blender. Drug Dev Ind Pharm, 29:679-687. (Pubitemid 36835161)
21. Abe H, Otsuka M. (2011). Effects of lubricant-mixing time on prolongation of dissolution time and its prediction by measuring near infrared spectra from tablets. Drug Dev Ind Pharm [Online], 1-8. Available at: http:// informahealthcare.com/doi/abs/10.3109/03639045.2011.608679?journalCode=ddi. Accessed on 5 February 2012.
22. Shah KR, Badawy SI, Szemraj MM, Gray DB, Hussain MA. (2007). Assessment of segregation potential of powder blends. Pharm Dev Technol, 12:457-462. (Pubitemid 350034878)
23. Alexander A, Roddy M, Brone D, Michaels J, Muzzio FJ. (2000). A method to quantitatively describe powder segregation during discharge from vessels. Pharm Tech Yearbook, 6-21.